Form 4: Aspira Women's Health Director Celeste Fralick Reports Stock Transactions
SEC Form 4 Filing
Director Celeste Fralick reports acquisition and disposal of Aspira Women's Health Inc. common stock on August 12, 2024, according to a Form 4 filing.
Summary
- Celeste Fralick, a director of Aspira Women's Health Inc., filed a Form 4 with the SEC.
- The report details changes in beneficial ownership of the company's common stock.
- On August 12, 2024, Fralick acquired 15,381 shares of common stock.
- These shares were obtained through restricted stock units that vested in full on the same date.
- Fralick also disposed of 40,665 shares.
- Following these transactions, Fralick directly owns 40,665 shares of Aspira Women's Health Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report their transactions in company stock, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- Shareholders are informed about the stock transactions of a company director, providing transparency into insider activity.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date of stock acquisition and disposal, and vesting of restricted stock units. |
| 08/13/2024 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Stock Transactions, Aspira Women's Health, Celeste Fralick, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.